Chinese Journal of Integrative Medicine

, Volume 14, Issue 3, pp 234–240

Current situation and progress in integrative medicine in China

  • Ai-ping Lu (吕爱平)
  • Xiao-rong Ding (丁晓蓉)
  • Ke-ji Chen (陈可冀)
Review
  • 151 Downloads

Abstract

In the past 50 years, integration of traditional Chinese medicine and Western medicine, known as the Chinese version of integrative medicine (IM), has achieved significant developments. In this article, the present situation and progress in IM development in China are summarized from the aspects of IM application, policy making, scientific research, education, academic exchanges, and its future development. With continuous support from the Chinese government and successful scientific achievements in the past 50 years, the authors believe that IM will be moving forwards to a full globalization.

Key Words

current situation and progress integrative medicine China 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wang ZR, Li JW, Chen KJ. Reviewing over the history of integrative medicine in China in 20th century. Chin J Integr Tradit West Med (Chin) 2005;25(11):1033–1037.Google Scholar
  2. 2.
    Chen KJ, Lu AP. Situation of integrative medicine in China: results from a national survey in 2004. Chin J Integr Med 2006;12(3):161–165.PubMedCrossRefGoogle Scholar
  3. 3.
    Lu AP, Chen KJ. Pondering on syndrome differentiation of diseases. Chin J Integr Tradit West Med (Chin) 2005;25(9):843–845.Google Scholar
  4. 4.
    He YT, Zha QL, Yan XP, et al. Analysis on symptomatic factors of rheumatoid arthritis and its correlation with therapeutic efficacy. Chin J Integr Tradit West Med (Chin) 2005;25(12):1077–1081.Google Scholar
  5. 5.
    Liu BY, Hu JQ, Xie YM, et al. Effects of integrative Chinese and Western medicine on arterial oxygen saturation in patients with severe acute respiratory syndrome. Chin J Integr Tradit West Med (Chin) 2004;10(2):117–122.Google Scholar
  6. 6.
    Chen KJ, Xu H, Shi DZ, et al. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China. Chin Med J 2006;119(1):6–13.PubMedGoogle Scholar
  7. 7.
    Xu H, Chen KJ, Shi DZ, et al. Clinical study of Xiongshao Capsule in preventing restenosis after coronary interventional treatment. Chin J Integr Med 2002;8(3):162–166.Google Scholar
  8. 8.
    Gao Y. Some key problems in study on clinical evaluation criterion for the combination of disease and syndrome of stroke. Chin J Integr Tradit West Med (Chin) 2007;27(9):778–779.Google Scholar
  9. 9.
    Gu WL, Shi ZX. The effective evaluation of TCM from viewpoint of cardiovascular disease. J Tradit Chin Med 2006;47(6):415–416.Google Scholar
  10. 10.
    Tang QS. Progress and commentary on research of integrated Chinese and Western medicine on poststroke depression. Chin J Integr Tradit West Med (Chin) 2007;27(9):776–777.Google Scholar
  11. 11.
    Liu QY, Song J, Chen KJ. Progress of studies on treatment of ischemic apoplexy by Chinese herbal medicine. Chin J Integr Tradit West Med (Chin) 2000;20(4):309–311.Google Scholar
  12. 12.
    Wu XZ. Modern research on purgation method of traditional Chinese medicine—application of the method in acute abdominal diseases and experimental studies. Chin J Integr Med 1998;4(1):5–8.Google Scholar
  13. 13.
    Shang TY. Treatment of fractures and joint injury by integrated traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 1988;8(Suppl 2):51–52.Google Scholar
  14. 14.
    Han JS. From acupuncture analgesia to heroin detoxification. Chin J Integr Med 1997;3(4):311–316.Google Scholar
  15. 15.
    Li TQ, Mao B, Wang G, et al. Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine. Chin J Integr Med 2008;14(1):6–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Lin L, Han Y, Yang ZM, et al. Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western medicine. Chin J Integr Tradit West Med (Chin) 2003;23(6):409–413.Google Scholar
  17. 17.
    Guan FL. The summary of acute pancreatitis treated with Chinese and Western medinice. The 9th National Academic Conference of Integrative Medicine on General Surgery, 2005:66–70Google Scholar
  18. 18.
    The Coorperation Group of Phase I Clinical Trial of Compound Huangdai Tablet. Phase I clinical trial of compound Huangdai Tablet in newly diagnosed acute promyelocytic leukemia. Chin J Hemat (Chin) 2006;27(12):801–804.Google Scholar
  19. 19.
    Pan YL, Pan YZ. Observation on effects of Zhiling Capsule (志苓胶囊) in treating 400 patients with various types of cancer in mid-advanced stage. Chin J Integr Tradit West Med (Chin) 2007;27(9):807–809.Google Scholar
  20. 20.
    Zhou DH, Lin LZ, Zhou YQ, et al. Analysis of short-term therapeutic efficacy of integrated traditional and Western medicine in treating non-small cell lung cancer. Chin J Integr Tradit West Med (Chin) 2005;25(12):1061–1065.Google Scholar
  21. 21.
    Chen XM, Chen J, Chen YP, et al. Multicentered, randomized, controlled clinical trial on patients with IgA nephropathy of qi-yin deficiency syndrome type. Chin J Integr Tradit West Med (Chin) 2007;27(2):101–105.Google Scholar
  22. 22.
    Lei Y, Lu QS, Ma XC, et al. Clinical study on effect of Qingxin Capsule (清心胶囊) in treating patients with hypertension of mild or moderate degree. Chin J Integr Tradit West Med (Chin) 2005;25(2):114–118.Google Scholar
  23. 23.
    Lu AP. Making repeated clinical trials aiming at finding specific indications is the way for improving clinical efficacy of traditional Chinese medicine. Chin J Integr Tradit West Med (Chin) 2006;26(7):588–589.Google Scholar
  24. 24.
    He YT, Lu AP, Lu C, et al. Symptom combinations assessed in traditional Chinese medicine and its predictive role in ACR20 efficacy response in rheumatoid arthritis. Am J Chin Med 2008;36:1–9.CrossRefGoogle Scholar
  25. 25.
    He YT, Lu AP, Zha YL, et al. Differential effect on symptoms treated with traditional Chinese medicine and Western combination therapy in RA patients. Complement Ther Med 2008;16:206–211.PubMedCrossRefGoogle Scholar
  26. 26.
    Lei Y, Chen KJ, Liu JG, et al. Effect of Xuefu Zhuyu Pill (血府逐瘀丸) on platelet activating factor expression in patients with unstable angina pectoris. Chin J Integr Med 2002;8(4):267–270.Google Scholar
  27. 27.
    Shen ZY. The location of deficiency syndrome of kidney Yang. Chin Med J 1999;112(11):973–975.PubMedGoogle Scholar
  28. 28.
    Duan YL, Zhang XM, Shen ZY, et al. Effect of three composite recipes on content of monoamine transmitters in hypothalamus induced by intracerebroventricular injection of interleukin-1 in rats. Chin J Integr Tradit West Med (Chin) 1999;19(3):164–166.Google Scholar
  29. 29.
    Shen ZY, Chen Y, Huang JH, et al. Syndrome differentiation through drug effects in mapping the two regulatory pathways of gene networks in Shen deficiency syndrome. Chin J Integr Tradit West Med (Chin) 2006;26(6):521–525.Google Scholar
  30. 30.
    Lu AP. Influence of TCM syndrome theory on thoughts of diseases treatment. Chin J Integr Tradit West Med (Chin) 2001;21(4):309–311.Google Scholar
  31. 31.
    He YT, Lu AP, Zha QL, et al. Correlations between symptoms as assessed in traditional Chinese medicine (TCM) and ACR20 efficacy response. A comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine. J Clin Rheumatol 2007;13:317–321.PubMedCrossRefGoogle Scholar
  32. 32.
    Li Y, Li S, Lu AP. Comparative analysis via data mining on the clinical features of Western medicine and Chinese medicine in diagnosing rheumatoid arthritis. Chin J Integr Tradit West Med (Chin) 2006;26(11):988–991.Google Scholar
  33. 33.
    Li S, Lu AP, Zhang L, et al. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions. World J Gastroenterol 2003;9:755–758.PubMedGoogle Scholar
  34. 34.
    Shen LS, Cai YX, Liu CJ, et al. Recent advances in TCM tongue manifestation information acquisition and analysis. World Sci Technol-Modern Tradit Chin Med 2007;9(5):97–101.Google Scholar
  35. 35.
    Jiang B, Song ZC, Yu P. The development overview of pulse transducer. Sci Technol Inform (Chin) 2007;5:22.Google Scholar
  36. 36.
    Zhu QW, Niu X, Yang J, et al. Methodology approach of pulse diagnosis research based on complexity science theory. China J Tradit Chin Med Pharm 2007;22(5):265–268.Google Scholar
  37. 37.
    Tan B, Song JP, Thou Tharith, et al. Radomized controlled trial of two kinds of compound dihydroartemisinin with or without trimethoprim for uncomplicated falciparum malaria. J Gungzhou Univ Tradit Chin Med (Chin) 2007;24(2):100–103.Google Scholar
  38. 38.
    Yue L, Zhu DN, Yan YQ, et al. Relationship between components changes and efficacy of Shengmaisan VII. Chemical dynamic change of schisandrin in Shengmaisan. China J Chin Materia Medica (Chin) 2006;31(12):1010–1012.Google Scholar
  39. 39.
    Zhang ZJ, Li P, Wang Z, et al. A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury. Brain Res 2006;1123:188–195.PubMedCrossRefGoogle Scholar
  40. 40.
    Wang L, Zhou GB, Chen Z, et al. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A 2008;105:4826–4831.PubMedCrossRefGoogle Scholar
  41. 41.
    Cheng Y, Chen M, Tong W. An approach to comparative analysis of chromatographic fingerprints for assuring the quality of botanical drugs. J Chem Inf Comput Sci 2003;43:1068–1076.PubMedGoogle Scholar
  42. 42.
    Zhang WD, Lu C, Zhao HY, et al. Effect of combination glycyrrhizin and triptolide on TNF-α and IL-10 in serum of collagen induced arthritis rats. China J Chin Materia Medica (Chin) 2007;32(5):414–417.Google Scholar
  43. 43.
    Xiao C, Lu C, Lu AP, et al. The effects of triptolide on enteric mucosal immune responses of DBA/1 mice with collagen induced arthritis. Planta Med 2006;72:1268–1272.PubMedCrossRefGoogle Scholar
  44. 44.
    Zhang QZ, Wu XJ, Li D, et al. Comparison of DNA fingerprinting and active compound content among different species of Radix Astragali. China J Chin Materia Medica (Chin) 2005;40(6):457–459.Google Scholar
  45. 45.
    Liu ZL, Li LF, Song ZQ, et al. New chemical constituents from Radix Polygoni Multiflori after processing. J Chin Med Materials (Chin) 2007;30(12):1505–1507.Google Scholar
  46. 46.
    Lu AP, Li CS. The pathologic mechanism research on kidney deficiency arthralgia zheng. J Tradit Chin Med (Chin) 1995;36(8):492–493.Google Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag GmbH 2008

Authors and Affiliations

  • Ai-ping Lu (吕爱平)
    • 1
  • Xiao-rong Ding (丁晓蓉)
    • 1
  • Ke-ji Chen (陈可冀)
    • 1
  1. 1.Chinese Association of Integrative MedicineChina Academy of Chinese Medical SciencesBeijingChina

Personalised recommendations